Multiplex Assay Kit for Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay)

BMP2B; BMP2-B; BMP2B1; ZYME; DVR4; Bone morphogenetic protein 2B

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 88-95 91
EDTA plasma(n=5) 81-98 92
heparin plasma(n=5) 83-90 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-92% 87-95% 81-91% 89-98%
EDTA plasma(n=5) 88-99% 97-105% 90-99% 79-102%
heparin plasma(n=5) 86-103% 78-103% 84-93% 86-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:BMP4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Cellular Biochemistry Titanium with Nanotopography Induces Osteoblast Differentiation by Regulating Endogenous Bone Morphogenetic Protein Expression and Signaling Pathway PubMed: 26681207
Domestic Animal Endocrinology Expression analysis of bone morphogenetic protein 4 between fat and lean birds in adipose tissue and serum Pubmed:26945137
FEBS Open Bio Bone morphogenetic protein 4 (BMP 4) regulates immortalized chicken preadipocyte proliferation by promoting G1/S cell cycle progression Pubmed: 30972973
Arch Gynecol Obstet The relationship between transforming growth factor β superfamily members (GDF11 and BMP4) and lumbar spine bone mineral density in postmenopausal Chinese … 34417839
Catalog No. Related products for research use of Oryctolagus cuniculus (Rabbit) Organism species Applications (RESEARCH USE ONLY!)
RPA014Rb03 Recombinant Bone Morphogenetic Protein 4 (BMP4) Positive Control; Immunogen; SDS-PAGE; WB.
RPA014Rb01 Recombinant Bone Morphogenetic Protein 4 (BMP4) Positive Control; Immunogen; SDS-PAGE; WB.
RPA014Rb02 Recombinant Bone Morphogenetic Protein 4 (BMP4) Positive Control; Immunogen; SDS-PAGE; WB.
PAA014Rb51 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC; IP.
PAA014Rb01 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC; IP.
PAA014Rb02 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC; IP.
PAA014Rb53 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC; IP.
PAA014Rb52 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC; IP.
LAA014Rb71 Biotin-Linked Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4) WB; IHC; ICC.
SEA014Rb ELISA Kit for Bone Morphogenetic Protein 4 (BMP4) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA014Rb CLIA Kit for Bone Morphogenetic Protein 4 (BMP4) Chemiluminescent immunoassay for Antigen Detection.
LMA014Rb Multiplex Assay Kit for Bone Morphogenetic Protein 4 (BMP4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.